Nathan Blake

Mr. Nathan Blake

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
NBNathan Blake
Nathan Blake
RGRiana Gaifulina
Riana Gaifulina
LGLewis D. Griffin
Lewis D. Griffin
IBIan Bell
Ian Bell
GTGeraint M. H. Thomas
Geraint M. H. Thomas
Raman Spectroscopy has long been anticipated to augment clinical decision making, such as classifying oncological samples. Unfortunately, the complexity of Raman data has thus far inhibited their routine use in clinical settings. Traditional machine learning models have been used to help exploit this information, but recent advances in deep learning have the potential to improve the field. However, there are a number of potential pitfalls with both traditional and deep learning models. We conduct a literature review to ascertain the recent machine learning methods used to classify cancers using Raman spectral data. We find that while deep learning models are popular, and ostensibly outperform traditional learning models, there are many methodological considerations which may be leading to an over-estimation of performance; primarily, small sample sizes which compound sub-optimal choices regarding sampling and validation strategies. Amongst several recommendations is a call to collate large benchmark Raman datasets, similar to those that have helped transform digital pathology, which researchers can use to develop and refine deep learning models.

11 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
NBNathan Blake
Nathan Blake
RGRiana Gaifulina
Riana Gaifulina
LGLewis D. Griffin
Lewis D. Griffin
IBIan Bell
Ian Bell
MRManuel Rodriguez-Justo
Manuel Rodriguez-Justo
GTGeraint M. H. Thomas
Geraint M. H. Thomas
Defective DNA mismatch repair is one pathogenic pathway to colorectal cancer. It is characterised by microsatellite instability which provides a molecular biomarker for its detection. Clinical guidelines for universal testing of this biomarker are not met due to resource limitations; thus, there is interest in developing novel methods for its detection. Raman spectroscopy (RS) is an analytical tool able to interrogate the molecular vibrations of a sample to provide a unique biochemical fingerprint. The resulting datasets are complex and high-dimensional, making them an ideal candidate for deep learning, though this may be limited by small sample sizes. This study investigates the potential of using RS to distinguish between normal, microsatellite stable (MSS) and microsatellite unstable (MSI-H) adenocarcinoma in human colorectal samples and whether deep learning provides any benefit to this end over traditional machine learning models. A 1D convolutional neural network (CNN) was developed to discriminate between healthy, MSI-H and MSS in human tissue and compared to a principal component analysis–linear discriminant analysis (PCA–LDA) and a support vector machine (SVM) model. A nested cross-validation strategy was used to train 30 samples, 10 from each group, with a total of 1490 Raman spectra. The CNN achieved a sensitivity and specificity of 83% and 45% compared to PCA–LDA, which achieved a sensitivity and specificity of 82% and 51%, respectively. These are competitive with existing guidelines, despite the low sample size, speaking to the molecular discriminative power of RS combined with deep learning. A number of biochemical antecedents responsible for this discrimination are also explored, with Raman peaks associated with nucleic acids and collagen being implicated.

13 May 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
NBNathan Blake
Nathan Blake
RGRiana Gaifulina
Riana Gaifulina
LGLewis D. Griffin
Lewis D. Griffin
IBIan Bell
Ian Bell
GTGeraint M. H. Thomas
Geraint M. H. Thomas
Raman Spectroscopy has long been anticipated to augment clinical decision making, such as classifying oncological samples. Unfortunately, the complexity of Raman data has thus far inhibited its routine use in clinical settings. Traditional machine learning models have been used to help exploit this information, but recent advances in deep learning have the potential to improve the field. However, there are a number of potential pitfalls with both traditional and deep learning models. We conduct a literature review to ascertain the recent machine learning methods used to classify cancers using Raman spectral data. We find that while deep learning models are popular, and ostensibly outperform traditional learning models, there are many methodological considerations which may be leading to an over-estimation of performance: primarily, small sample sizes which compound upon sub-optimal choices regarding sampling and validation strategies. Amongst several recommendations is a call to collate large benchmark Raman datasets, similar to those that have helped transform digital pathology, which researchers can use to develop and refine deep learning models.

23 July 2024 in BJC Reports
Verified
Journal Article
Open access
PDF file
NBNathan Blake
Nathan Blake
RGRiana Gaifulina
Riana Gaifulina
MIMartin Isabelle
Martin Isabelle
JDJennifer Dorney
Jennifer Dorney
MRManuel Rodriguez-Justo
Manuel Rodriguez-Justo
GTGeraint M. H. Thomas
Geraint M. H. Thomas
Background: The clinical potential of Raman spectroscopy is well established but has yet to become established in routine oncology workflows. One barrier slowing clinical adoption is a lack of evidence demonstrating that data taken on one spectrometer transfers across to data taken on another spectrometer to provide consistent diagnoses. Methods: We investigated multi-centre transferability using human oesophageal tissue. Raman spectra were taken across three different centres with different spectrometers of the same make and model. By using a common protocol, we aimed to minimise the difference in machine learning performance between centres. Results: 61 oesophageal samples from 51 patients were interrogated by Raman spectroscopy at each centre and classified into one of five pathologies. The overall accuracy and log-loss did not significantly vary when a model trained upon data from any one centre was applied to data taken at the other centres. Computational methods to correct for the data during pre-processing were not needed. Conclusion: We have found that when using the same make and model of spectrometer, together with a common protocol, across different centres it is possible to achieve system transferability without the need for additional computational instrument correction.

11 November 2025
Verified
Book Chapter
Closed access
PDF file
NBNathan Blake
Nathan Blake
DKDavid Kelly
David Kelly
ACAkchunya Chanchal
Akchunya Chanchal
SKSarah Kapllani-Mucaj
Sarah Kapllani-Mucaj
GTGeraint M. H. Thomas
Geraint M. H. Thomas
HCHana Chockler
Hana Chockler

2 April 2026 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
SOSiobhan O'COnnor
Siobhan O'COnnor
MZMengying Zhang
Mengying Zhang
DWDaniel Wicks
Daniel Wicks
XLXiaoyang Li
Xiaoyang Li
HCHelen Caton-Peters
Helen Caton-Peters
NBNathan Blake
Nathan Blake